Stifel Reiterates Hold Rating on MacroGenics (MGNX): "MGC026 dose-escalation/expansion data should read well"
Tweet Send to a Friend
Stifel analyst Stephen Willey reiterated a Hold rating and $4.00 price target on MacroGenics (NASDAQ: MGNX)The analyst commented, "The provision ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
